Tenaya Therapeutics, Inc. (TNYA) Operating income 2020–2025
Tenaya Therapeutics, Inc. (TNYA) annual operating income history from SEC filings — each fiscal year as reported.
-$93.3MFY2025 · since FY2020: -$38.9M → -$93.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.3M | +19.5% |
| FY2024 | -$115.9M | +11.6% |
| FY2023 | -$131.2M | -4.4% |
| FY2022 | -$125.6M | -72.5% |
| FY2021 | -$72.8M | -87.1% |
| FY2020 | -$38.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice